Addex Pharma S.A. / “Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Dipraglurant (ADX48621) for the Treatment
Date Published March 17, 2026
No summary available
COM Affiliation
Funding Type
Corporate Grant (for-profit and non-profit)
Update This Listing
Help us provide the most up-to-date information about this project.
Contact UsQuestions?
For questions about these research projects please email us.
Contact Us